13 commercial payer policies list J9053. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
13 policies from 11 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J9053 |
|---|---|---|
| Belantamab mafodotin-blmf (Blenrep) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Belantamab mafodotin-blmf (Blenrep) | Not recorded | Covered with conditionsInferred from policy title |
| Policy | Effective | Status of J9053 |
|---|---|---|
| Belantamab mafodotin-blmf (Blenrep) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Belantamab mafodotin-blmf (Blenrep) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9053 |
|---|---|---|
| Belantamab mafodotin-blmf (e.g., Blenrep) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9053 |
|---|---|---|
| BLENREP (BELANTAMAB MAFODOTIN-BLMF) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9053 |
|---|---|---|
| Belantamab Mafodotin Blenrep | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9053 |
|---|---|---|
| Belantamab Mafodotin-blmf (Blenrep) | Jan 30, 2026 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9053 |
|---|---|---|
| Cigna MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J9053 |
|---|---|---|
| Belantamab Mafodotin-blmf (Blenrep); CP.PHAR.469 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9053 |
|---|---|---|
| Q4 - 2026 JHP MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J9053 |
|---|---|---|
| Oncology - belantamab (Blenrep) – Minnesota Health Care Programs | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9053 |
|---|---|---|
| Blenrep (belantamab mafodotin-blmf) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |